Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Larmonier

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|November 5, 2015
Generation and Expansion of T Helper 17 Lymphocytes Ex VivoDarya Alizadeh, Nicolas Larmonier
Cancer Research|April 30, 2014
Chemotherapeutic targeting of cancer-induced immunosuppressive cellsDarya Alizadeh, Nicolas Larmonier
Oncoimmunology|March 22, 2014
Chemotherapeutic targeting of myeloid-derived suppressor cellsDarya Alizadeh, Emmanuel Katsanis, Nicolas Larmonier
Immunotherapy|February 18, 2010
Personalized dendritic cell-based tumor immunotherapyNona Janikashvili, Nicolas Larmonier, Emmanuel Katsanis
Oncoimmunology|July 4, 2012
Cytotoxic and antigen presenting functions of T helper-1-activated dendritic cellsNicolas Larmonier, Bernard Bonnotte, Emmanuel Katsanis
Clinical & Developmental Immunology|January 24, 2014
The multifaceted role of Th17 lymphocytes and their associated cytokines in cancerDarya Alizadeh, Emmanuel Katsanis, Nicolas Larmonier
Frontiers in Immunology|March 20, 2023
Editorial: Tumor-promoting immune cells: Cancer immune escape and beyondCharlotte Domblides, Darya Alizadeh, Nicolas Larmonier
Cellular Immunology|March 5, 2010
DC-expressed MHC class I single-chain trimer-based vaccines prime cytotoxic T lymphocytes against exogenous but not endogenous antigensMaria L Ordaz, Nicolas Larmonier, Lonnie Lybarger
Elife|November 30, 2019
Characterizing causality in cancerElena Rondeau, Nicolas Larmonier, Thomas Pradeu, et al.
Cells|February 15, 2022
Influence of the Metabolism on Myeloid Cell Functions in Cancers: Clinical PerspectivesThomas Boyer, Céline Blaye, Nicolas Larmonier, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Methods in Molecular Biology (Clifton, N.J.)|November 5, 2015
Generation and Expansion of T Helper 17 Lymphocytes Ex VivoDarya Alizadeh, Nicolas Larmonier
Cancer Research|April 30, 2014
Chemotherapeutic targeting of cancer-induced immunosuppressive cellsDarya Alizadeh, Nicolas Larmonier
Oncoimmunology|March 22, 2014
Chemotherapeutic targeting of myeloid-derived suppressor cellsDarya Alizadeh, Emmanuel Katsanis, Nicolas Larmonier
Immunotherapy|February 18, 2010
Personalized dendritic cell-based tumor immunotherapyNona Janikashvili, Nicolas Larmonier, Emmanuel Katsanis
Oncoimmunology|July 4, 2012
Cytotoxic and antigen presenting functions of T helper-1-activated dendritic cellsNicolas Larmonier, Bernard Bonnotte, Emmanuel Katsanis
Clinical & Developmental Immunology|January 24, 2014
The multifaceted role of Th17 lymphocytes and their associated cytokines in cancerDarya Alizadeh, Emmanuel Katsanis, Nicolas Larmonier
Frontiers in Immunology|March 20, 2023
Editorial: Tumor-promoting immune cells: Cancer immune escape and beyondCharlotte Domblides, Darya Alizadeh, Nicolas Larmonier
Cellular Immunology|March 5, 2010
DC-expressed MHC class I single-chain trimer-based vaccines prime cytotoxic T lymphocytes against exogenous but not endogenous antigensMaria L Ordaz, Nicolas Larmonier, Lonnie Lybarger
Elife|November 30, 2019
Characterizing causality in cancerElena Rondeau, Nicolas Larmonier, Thomas Pradeu, et al.
Cells|February 15, 2022
Influence of the Metabolism on Myeloid Cell Functions in Cancers: Clinical PerspectivesThomas Boyer, Céline Blaye, Nicolas Larmonier, et al.
Pageof 6